W
William O. Cooper
Researcher at Vanderbilt University Medical Center
Publications - 177
Citations - 9771
William O. Cooper is an academic researcher from Vanderbilt University Medical Center. The author has contributed to research in topics: Pregnancy & Retrospective cohort study. The author has an hindex of 48, co-authored 162 publications receiving 8729 citations. Previous affiliations of William O. Cooper include Vanderbilt University & Monroe Carell Jr. Children's Hospital at Vanderbilt.
Papers
More filters
Journal ArticleDOI
Major Congenital Malformations after First-Trimester Exposure to ACE Inhibitors
William O. Cooper,Sonia Hernandez-Diaz,Patrick G. Arbogast,Judith A. Dudley,Shannon M. Dyer,Patricia Gideon,Kathi Hall,Wayne A. Ray +7 more
TL;DR: Exposure to ACE inhibitors during the first trimester cannot be considered safe and should be avoided, and infants born between 1985 and 2000 for whom there was no evidence of maternal diabetes are studied.
Journal ArticleDOI
Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012.
TL;DR: Neonatal abstinence syndrome (NAS), a postnatal opioid withdrawal syndrome, increased threefold from 2000 to 2009 and hospital charges grew substantially during the study period, with 81% attributed to state Medicaid programs in 2012.
Journal ArticleDOI
Comparative Effects of Therapy With Captopril and Digoxin in Patients With Mild to Moderate Heart Failure
Jay N. Cohn,Morton Hawkins,Herbert J. Levine,John Naughton,Elliot Rapaport,Sidney Goldstein,Bertram Pitt,Robert Cody,Prakash Deedwania,Leonard Dennick,Joseph A. Franciosa,Mark McGovern,Joseph J. Meyer,Alan Gradman,Barry M. Massie,Milton Packer,James E. Doherty,Jacquelyn Gammill,William O. Cooper,Stanford Engel,Rita Fand,Barbara Hallows,Linda Kerwin,Debra A. Soltesz,John O. Parker,Karen Lahey,Prakash Deedwania,Enrique V. Carbajal,Pat Watson,Robert DiBianco,James A. Ronan,Dennis J. Donohue,Keith M. Lindgren,Louis J. Larca,Judy Freitag,Donna Lindemuth,Jeffrey B. Lakier,Howard S. Rosman,Mary Beth Wlodkowski,Robert J. Cody,Spencer H. Kubo,Mary Clark,Katie Pondolfino,Joseph A. Franciosa,Mary Wilen,Drexel Jordan,Sunil K. Das,John M. Nicklas,Mary Kay Foley,Michael B. Higginbotham,Frederick R. Cobb,Jean D. Wilson,David M. Berkson,Dragic Obradovic,Patricia Hershinow,N. Gary Nicholls,Hamid Ikram,Ian Crozier,Carl J. Pepine,John Culp,Marion Limacher,Kathy Mulvehill-Verbust,D. John Farnham,Dorothy Adams,Norene Streicher,Carol Shanley,Mark A. Greenberg,Janet Strain,Mary Hewitt,Barbara Levine,D. Norman Sharpe,Robin Briant,Rene Coxon,Barry M. Massie,James W. Cornyn,Nina Topic,Harold Willens,Denise Antonishen,Dorothy Reinstein,Harry F. Colfer,Karen E. Graham,Gerald M. Perlow,Harvey S. Zarren,Barbara Bent,Marjorie Zicherman,Barry Zaret,Deborah Lawrason,Pat Tellier,Kathy O'Keefe,Syed M. Mohiuddin,Lois Stengel,James D. Madison,Nancy Carruthers,Fernando Elijovich,Mary Jo O'Sullivan,Uri Elkayam,Shabudin H. Rahimtoola,Laura Weber,Sheldon K. Gottlieb,Carol L. Brown,Mariell D. Jessup,Susan Ulrich,Jane Kronenthal,Denise Capaccio,Colin Grant,Edward Gillie,Pat Wood,Fetnat M. Fouad-Tarazi,Kay Petey +108 more
TL;DR: Captopril treatment is significantly more effective than placebo and is an alternative to digoxin therapy in patients with mild to moderate heart failure who are receiving diuretic maintenance therapy.
Journal ArticleDOI
Increasing use of antidepressants in pregnancy
TL;DR: There is an urgent need for further studies that better quantify the fetal consequences of exposure to antidepressants in women enrolled in Tennessee Medicaid from 1999-2003.
Journal ArticleDOI
ADHD Drugs and Serious Cardiovascular Events in Children and Young Adults
William O. Cooper,Laurel A. Habel,Colin M. Sox,K. Arnold Chan,Patrick G. Arbogast,T. Craig Cheetham,Katherine T. Murray,Virginia P. Quinn,C. Michael Stein,S. Todd Callahan,Bruce Fireman,Frank A. Fish,Howard S. Kirshner,Anne E. O’Duffy,Frederick A. Connell,Wayne A. Ray +15 more
TL;DR: No evidence was found that current use of an ADHD drug was associated with an increased risk of serious cardiovascular events, although the upper limit of the 95% confidence interval indicated that a doubling of the risk could not be ruled out.